EUVIMEDScopri EUVIMED
Randomisierte kontrollierte StudieOpen access

Effect of behavioral weight‐loss program on biomarkers of cardiometabolic disease risk: Heart Health Study randomized trial

Katherine A Collins iD, William E Kraus, Renee J Rogers, Elizabeth R Hauser, Wei Lang, Rong Jiang, Erik B Schelbert, Kim M Huffman, John M Jakicic

Obesity · 2023-02 · 31 (2) · 338-349

DOI: 10.1002/oby.23618 ↗

At a glance

Randomisierte kontrollierte Studie in Obesity, published online on 2023-01-09. Written by Katherine A Collins and 8 co-authors. Institution: Duke Molecular Physiology Institute and Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA. Major MEDLINE topics: Weight Reduction Programs, Insulin Resistance, Cardiovascular Diseases. Cited 6 times so far (Crossref); 45 references. The full text is freely available in PubMed Central. Funded by: NCATS NIH HHS, NHLBI NIH HHS, NHGRI NIH HHS.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Objective

This study aimed to determine whether novel biomarkers of cardiometabolic health improve in response to a 12‐month behavioral weight‐loss intervention and to compare benefits of diet alone with diet plus physical activity for these biomarkers.

Methods

Participants ( N = 374) were randomized to either diet alone (DIET), diet plus 150 min/wk of prescribed moderate‐intensity physical activity (DIET + PA150), or diet plus 250 min/wk of prescribed moderate‐intensity physical activity (DIET + PA250). Biomarker concentrations were determined using nuclear magnetic resonance spectroscopy. Mixed models assessed for a time effect, group effect, or group by time interaction.

Results

All groups significantly improved body weight (time: p < 0.0001), Lipoprotein Insulin Resistance Index score (time: p < 0.0001), Diabetes Risk Index score (time: p < 0.0001), branched‐chain amino acid concentration (time: p < 0.0001), and GlycA concentration (time: p < 0.0001), with no group effect or group by time interactions.

Conclusions

All intervention groups prompted a notable beneficial change among biomarkers of insulin resistance and cardiometabolic health. However, the addition of at least moderate‐intensity physical activity to a diet‐only intervention did not provide any additional benefit. These findings highlight that an average weight loss of approximately 10% profoundly impacts biomarkers of insulin resistance and cardiometabolic disease in adults with overweight or obesity.

Subjects

MeSH terms (MEDLINE)

Weight Reduction ProgramsInsulin ResistanceCardiovascular DiseasesAdultHumansObesityOverweightWeight LossBiomarkers

Substances

Biomarkers

Authors and institutions

  • Duke Molecular Physiology Institute and Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.
  • Division of Cardiology, Duke University School of Medicine, Durham, North Carolina, USA.
  • Wondr Health, Dallas, Texas, USA.
  • Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, North Carolina, USA.
  • Cooperative Studies Program Epidemiology Center-Durham, Durham VA Health Care System, Durham, North Carolina, USA.
  • Center on Aging and Mobility, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

ORCID profiles: Katherine A Collins

Funding

  • NCATS NIH HHS
  • NHLBI NIH HHS
  • NHGRI NIH HHS
  • National Heart, Lung, and Blood Institute
  • National Institutes of Health
  • National Human Genome Research Institute

Cite

APA

Collins, K. A., Kraus, W. E., Rogers, R. J., Hauser, E. R., Lang, W., Jiang, R., Schelbert, E. B., Huffman, K. M., & Jakicic, J. M. (2023). Effect of behavioral weight‐loss program on biomarkers of cardiometabolic disease risk: Heart Health Study randomized trial. Obesity, 31(2), 338-349. https://doi.org/10.1002/oby.23618

Vancouver

Collins KA, Kraus WE, Rogers RJ, Hauser ER, Lang W, Jiang R, et al. Effect of behavioral weight‐loss program on biomarkers of cardiometabolic disease risk: Heart Health Study randomized trial. Obesity. 2023;31(2):338-349. doi:10.1002/oby.23618

BibTeX
@article{Collins2023,
  author = {Collins, Katherine A and Kraus, William E and Rogers, Renee J and Hauser, Elizabeth R and Lang, Wei and Jiang, Rong and Schelbert, Erik B and Huffman, Kim M and Jakicic, John M},
  title = {Effect of behavioral weight‐loss program on biomarkers of cardiometabolic disease risk: Heart Health Study randomized trial},
  journal = {Obesity},
  year = {2023},
  volume = {31},
  number = {2},
  pages = {338--349},
  doi = {10.1002/oby.23618}
}
Start for free →